Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
Humoral Immune Responses01:36

Humoral Immune Responses

82.7K
Overview
82.7K
Inflammatory Response01:28

Inflammatory Response

15.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

136
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
136
RNA Interference01:23

RNA Interference

27.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lost in translation: interferon-stimulated genes targeting flavivirus protein synthesis.

Journal of virology·2026
Same author

Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential.

Cell host & microbe·2026
Same author

Emergence of vaccine-derived poliovirus strains from the novel oral polio vaccine in the Central African Republic.

mBio·2026
Same author

Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cells.

PLoS pathogens·2026
Same author

Type I and III interferon responses restrict infection by tick-borne orthoflaviviruses through IFI6.

Journal of virology·2026
Same author

Noncanonical expression mechanisms in orthoflaviviruses.

Current opinion in virology·2026

Related Experiment Video

Updated: Dec 13, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.7K

Interplay between SARS-CoV-2 and the type I interferon response.

Margarida Sa Ribero1, Nolwenn Jouvenet2, Marlène Dreux1

  • 1CIRI, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, École Normale Supérieure de Lyon, Univ Lyon, Lyon, France.

Plos Pathogens
|July 30, 2020
PubMed
Summary
This summary is machine-generated.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disrupts the immune system, leading to severe COVID-19. Understanding type I interferon (IFN-I) responses is crucial for developing effective treatments against SARS-CoV-2.

More Related Videos

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

19.9K
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.4K

Related Experiment Videos

Last Updated: Dec 13, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.7K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

19.9K
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.4K

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes COVID-19, often linked to immune dysregulation.
  • Weak type I interferon (IFN-I) production and excessive inflammation contribute to severe COVID-19.
  • SARS-CoV-2 shares genetic traits with SARS-CoV and MERS-CoV, suggesting potential therapeutic overlaps.

Purpose of the Study:

  • To review current knowledge on SARS-CoV-2 interaction with the IFN system.
  • To identify knowledge gaps in understanding SARS-CoV-2 immune evasion mechanisms.
  • To discuss the therapeutic potential of IFN-I for COVID-19.

Main Methods:

  • Literature review of studies on SARS-CoV-2, IFN response, and related coronaviruses.
  • Analysis of conserved and novel IFN evasion strategies employed by SARS-CoV-2.
  • Examination of the role of plasmacytoid dendritic cells (pDCs) in IFN-I production.

Main Results:

  • SARS-CoV-2 utilizes conserved and novel mechanisms to evade the IFN response.
  • Significant advancements have been made in understanding IFN-I regulation and pDC function.
  • Clinical trials are evaluating IFN-I efficacy, but results are pending.

Conclusions:

  • IFN-I therapy holds potential for COVID-19, but timing and combination strategies are key.
  • Boosting pDC-mediated IFN responses early in infection may be beneficial.
  • Further research is needed to fully elucidate SARS-CoV-2's impact on the IFN system.